CJ
ACAD icon

Caitlin John’s Acadia Pharmaceuticals ACAD Stock Holding History

Caitlin John’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01K Hold
40
– – ﹤0.01% 861
2026
Q1 		$890 Hold
40
– – ﹤0.01% 815
2025
Q4 		$1.07K Sell
40
-35
-47% -$836 ﹤0.01% 789
2025
Q3 		$1.6K Buy
+75
New +$1.77K ﹤0.01% 712
2025
Q1 		– Sell
-75
Closed -$1.38K – 135
2024
Q4 		$1.38K Hold
75
– – ﹤0.01% 701
2024
Q3 		$1.32K Buy
+75
New +$1.25K ﹤0.01% 707

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Caitlin John's ACAD Position: Q2 2026 in Review

Caitlin John held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 40 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #861.

Caitlin John first reported a position in ACAD in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.6K in Q3 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Caitlin John held 40 shares of Acadia Pharmaceuticals worth $1.01K as of Q2 2026.
  • Caitlin John left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #861 holding.
  • Caitlin John first reported a position in Acadia Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Caitlin John's Acadia Pharmaceuticals position peaked at $1.6K in Q3 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.